Lv3
218 积分 2023-02-20 加入
Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases
14小时前
已完结
Discovery of C2: A Novel Lead Compound for the Treatment of Gout and Hyperuricemia via Multi‐Pathway Inhibition
2个月前
已完结
Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout
2个月前
已完结
Optimizing gout treatment: A comprehensive review of current and emerging uricosurics
2个月前
已完结
Benzoheterocyclic analogues of dotinurad as orally efficacious human urate transporter 1 inhibitors: Design, synthesis, structure-activity relationships, and pharmacokinetic studies
2个月前
已关闭
Targeted Treatment for Hyperuricemia: The Drug Pipeline
2个月前
已完结
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
2个月前
已完结
Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities
2个月前
已完结
Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1
3个月前
已完结
皖公网安备34019202002308
